Drug Development Gantt Chart
This is a practical guide to building a gantt chart for a drug development project — a bar-chart view of the schedule showing tasks, durations and dependencies, adapted to the realities of developing a pharmaceutical product through regulatory stages.
What a Gantt Chart is
A gantt chart is a bar-chart view of the schedule showing tasks, durations and dependencies. For the full concept and how it works in general, see Gantt Chart. On a drug development project it plays the same role, tuned to this kind of work.
Why it matters for a Drug Development project
Drug Development projects live or die on developing a pharmaceutical product through regulatory stages. A well-built gantt chart gives the team a shared, explicit reference for exactly that — reducing ambiguity, aligning stakeholders, and making problems visible early enough to act. Skipping it, or doing it generically, is how drug development projects drift into avoidable delay and cost.
What to include
- Task bars by start/end date
- Dependency links
- Milestones
- Owners/resources
- Baseline overlay
Drug Development-specific considerations
Tailor the gantt chart to the risks that most often derail drug development projects:
- Regulatory approval delays
- Trial/validation failures
- Strict GxP compliance
Example
On a real drug development project, the gantt chart would be shaped by developing a pharmaceutical product through regulatory stages. In particular, it should explicitly account for the project’s biggest risks — regulatory approval delays, trial/validation failures, strict GxP compliance — rather than treating them as afterthoughts.